ALAD Antikörper (N-Term)
Kurzübersicht für ALAD Antikörper (N-Term) (ABIN927973)
Target
Alle ALAD Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- Purified
-
Immunogen
- ALAD antibody was raised in rabbit using the N terminal of ALAD as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
ALAD Blocking Peptide, (ABIN5612000), is also available for use as a blocking control in assays to test for specificity of this ALAD antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- ALAD (Aminolevulinate Dehydratase (ALAD))
-
Andere Bezeichnung
- ALAD
-
Hintergrund
- The ALAD enzyme is composed of 8 identical subunits and catalyzes the condensation of 2 molecules of delta-aminolevulinate to form porphobilinogen (a precursor of heme, cytochromes and other hemoproteins). ALAD catalyzes the second step in the porphyrin and heme biosynthetic pathway, zinc is essential for enzymatic activity. ALAD enzymatic activity is inhibited by lead and a defect in the ALAD structural gene can cause increased sensitivity to lead poisoning and acute hepatic porphyria. Synonyms: Polyclonal ALAD antibody, Anti-ALAD antibody, aminolevulinate, delta-, dehydratase antibody, ALADH antibody, MGC5057 antibody, PBGS antibody.
Target
-